Exact Mass: 463.1887
Exact Mass Matches: 463.1887
Found 500 metabolites which its exact mass value is equals to given mass value 463.1887
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pivampicillin
Pivampicillin is only found in individuals that have used or taken this drug. It is an analog of ampicillin.Ampicillin (the active metabolite of pivampicillin) has a bactericidal action resulting from inhibition of cell wall mucopeptide biosynthesis. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D08396
Dihydroisomorphine-3-glucuronide
Dihydroisomorphine-3-glucuronide is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)
Dihydromorphine-3-glucuronide
Dihydromorphine-3-glucuronide is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)
Etodolac acyl glucuronide
Etodolac acyl glucuronide is a metabolite of etodolac. Etodolac: Etodolac belongs to a class of drugs called nonsteroidal anti-inflammatory drugs. Other members of this class include aspirin, ibuprofen (Motrin, Advil, Nuprin, etc. ), naproxen (Aleve, Naprosyn), indomethacin (Indocin), nabumetone (Relafen) and numerous others. These drugs are used for the management of mild to moderate pain, fever, and inflammation. (Wikipedia)
Dihydroisomorphine-6-glucuronide
Dihydroisomorphine-6-glucuronide is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)
4-Hydroxynonenal glutathione
4-Hydroxynonenal glutathione (4-HNE-GSH) is the conjugated product of 4-hydroxy-2-nonenal with glutathione that is synthesized from a reaction catalyzed by glutathione transferases (GSTs). 4-Hydroxy-2-nonenal (4-HNE) is a major lipid peroxidation end product that is known to be highly toxic and very stable. It has been implicated in the pathogenesis and progression of a multitude of human diseases (e.g. cataractogenesis, diabetes, atherosclerosis, osteoporosis, Alzheimers disease, Parkinsons disease, multiple schlerosis, cancer, etc.) (PMID: 23848536). The primary mechanism of 4-HNE detoxification is via its conjugation to glutathione (PMID: 12892994).
(2S,3R)-3-(4-Hydroxyphenyl)-2-(4-{[(2S)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL
1-Methyl-5-(4-benzoyl)pyrrole-2-acetic acid 2-(theophylline-7-yl)ethyl ester
N-Carbobenzoxyglycyl-prolyl-4-methylcoumarinyl amide
Lys Ser Asp Asp
Asp Ser Lys Asp
pivampicillin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D08396
8-2-Amino-3-methylimidazo[4,5-f]quinoline-deoxyguanosine
Ala Cys Asp Arg
Ala Cys Arg Asp
Ala Asp Cys Arg
Ala Asp Met Gln
Ala Asp Gln Met
Ala Asp Arg Cys
Ala Glu Met Asn
Ala Glu Asn Met
Ala Gly Met Trp
Ala Gly Trp Met
Ala Met Asp Gln
Ala Met Glu Asn
Ala Met Gly Trp
Ala Met Asn Glu
Ala Met Gln Asp
Ala Met Trp Gly
Ala Asn Glu Met
Ala Asn Met Glu
Ala Gln Asp Met
Ala Gln Met Asp
Ala Arg Cys Asp
Ala Arg Asp Cys
Ala Trp Gly Met
Ala Trp Met Gly
Cys Ala Asp Arg
Cys Ala Arg Asp
Cys Asp Ala Arg
Cys Asp Ile Asn
Cys Asp Leu Asn
Cys Asp Asn Ile
Cys Asp Asn Leu
Cys Asp Gln Val
Cys Asp Arg Ala
Cys Asp Val Gln
Cys Glu Gly Arg
Cys Glu Asn Val
Cys Glu Arg Gly
Cys Glu Val Asn
Cys Gly Glu Arg
Cys Gly Arg Glu
Cys Gly Val Trp
Cys Gly Trp Val
Cys Ile Asp Asn
Cys Ile Asn Asp
Cys Leu Asp Asn
Cys Leu Asn Asp
Cys Asn Asp Ile
Cys Asn Asp Leu
Cys Asn Glu Val
Cys Asn Ile Asp
Cys Asn Leu Asp
Cys Asn Val Glu
Cys Gln Asp Val
Cys Gln Val Asp
Cys Arg Ala Asp
Cys Arg Asp Ala
Cys Arg Glu Gly
Cys Arg Gly Glu
Cys Val Asp Gln
Cys Val Glu Asn
Cys Val Gly Trp
Cys Val Asn Glu
Cys Val Gln Asp
Cys Val Trp Gly
Cys Trp Gly Val
Cys Trp Val Gly
Asp Ala Cys Arg
Asp Ala Met Gln
Asp Ala Gln Met
Asp Ala Arg Cys
Asp Cys Ala Arg
Asp Cys Ile Asn
Asp Cys Leu Asn
Asp Cys Asn Ile
Asp Cys Asn Leu
Asp Cys Gln Val
Asp Cys Arg Ala
Asp Cys Val Gln
Asp Asp Lys Ser
Asp Asp Ser Lys
Asp Ile Cys Asn
Asp Ile Asn Cys
Asp Lys Asp Ser
Asp Lys Ser Asp
Asp Leu Cys Asn
Asp Leu Asn Cys
Asp Met Ala Gln
Asp Met Gln Ala
Asp Asn Cys Ile
Asp Asn Cys Leu
Asp Asn Ile Cys
Asp Asn Leu Cys
Asp Gln Ala Met
Asp Gln Cys Val
Asp Gln Met Ala
Asp Gln Thr Thr
Asp Gln Val Cys
Asp Arg Ala Cys
Asp Arg Cys Ala
Asp Arg Ser Ser
Asp Ser Asp Lys
Asp Ser Arg Ser
Asp Ser Ser Arg
Asp Thr Gln Thr
Asp Thr Thr Gln
Asp Val Cys Gln
Asp Val Gln Cys
Glu Ala Met Asn
Glu Ala Asn Met
Glu Cys Gly Arg
Glu Cys Asn Val
Glu Cys Arg Gly
Glu Cys Val Asn
Glu Gly Cys Arg
Glu Gly Met Gln
Glu Gly Gln Met
Glu Gly Arg Cys
Glu Met Ala Asn
Glu Met Gly Gln
Glu Met Asn Ala
Glu Met Gln Gly
Glu Asn Ala Met
Glu Asn Cys Val
Glu Asn Met Ala
Glu Asn Thr Thr
Glu Asn Val Cys
Glu Gln Gly Met
Glu Gln Met Gly
Glu Gln Ser Thr
Glu Gln Thr Ser
Glu Arg Cys Gly
Glu Arg Gly Cys
Glu Ser Gln Thr
Glu Ser Thr Gln
Glu Thr Asn Thr
Glu Thr Gln Ser
Glu Thr Ser Gln
Glu Thr Thr Asn
Glu Val Cys Asn
Glu Val Asn Cys
Gly Ala Met Trp
Gly Ala Trp Met
Gly Cys Glu Arg
Gly Cys Arg Glu
Gly Cys Val Trp
Gly Cys Trp Val
Gly Glu Cys Arg
Gly Glu Met Gln
Gly Glu Gln Met
Gly Glu Arg Cys
Gly His His Asn
Gly His Asn His
Gly Met Ala Trp
Gly Met Glu Gln
Gly Met Gln Glu
Gly Met Trp Ala
Gly Asn His His
Gly Gln Glu Met
Gly Gln Met Glu
Gly Arg Cys Glu
Gly Arg Glu Cys
Gly Val Cys Trp
Gly Val Trp Cys
Gly Trp Ala Met
Gly Trp Cys Val
Gly Trp Met Ala
Gly Trp Val Cys
His Gly His Asn
His Gly Asn His
His His Gly Asn
His His Asn Gly
His Asn Gly His
His Asn His Gly
Ile Cys Asp Asn
Ile Cys Asn Asp
Ile Asp Cys Asn
Ile Asp Asn Cys
Ile Asn Cys Asp
Ile Asn Asp Cys
Lys Asp Asp Ser
Lys Asp Ser Asp
Leu Cys Asp Asn
Leu Cys Asn Asp
Leu Asp Cys Asn
Leu Asp Asn Cys
Leu Asn Cys Asp
Leu Asn Asp Cys
Met Ala Asp Gln
Met Ala Glu Asn
Met Ala Gly Trp
Met Ala Asn Glu
Met Ala Gln Asp
Met Ala Trp Gly
Met Asp Ala Gln
Met Asp Gln Ala
Met Glu Ala Asn
Met Glu Gly Gln
Met Glu Asn Ala
Met Glu Gln Gly
Met Gly Ala Trp
Met Gly Glu Gln
Met Gly Gln Glu
Met Gly Trp Ala
Met Asn Ala Glu
Met Asn Glu Ala
Met Gln Ala Asp
Met Gln Asp Ala
Met Gln Glu Gly
Met Gln Gly Glu
Met Trp Ala Gly
Met Trp Gly Ala
Asn Ala Glu Met
Asn Ala Met Glu
Asn Cys Asp Ile
Asn Cys Asp Leu
Asn Cys Glu Val
Asn Cys Ile Asp
Asn Cys Leu Asp
Asn Cys Val Glu
Asn Asp Cys Ile
Asn Asp Cys Leu
Asn Asp Ile Cys
Asn Asp Leu Cys
Asn Glu Ala Met
Asn Glu Cys Val
Asn Glu Met Ala
Asn Glu Thr Thr
Asn Glu Val Cys
Asn Gly His His
Asn His Gly His
Asn His His Gly
Asn Ile Cys Asp
Asn Ile Asp Cys
Asn Leu Cys Asp
Asn Leu Asp Cys
Asn Met Ala Glu
Asn Met Glu Ala
Asn Thr Glu Thr
Asn Thr Thr Glu
Asn Val Cys Glu
Asn Val Glu Cys
Gln Ala Asp Met
Gln Ala Met Asp
Gln Cys Asp Val
Gln Cys Val Asp
Gln Asp Ala Met
Gln Asp Cys Val
Gln Asp Met Ala
Gln Asp Thr Thr
Gln Asp Val Cys
Gln Glu Gly Met
Gln Glu Met Gly
Gln Glu Ser Thr
Gln Glu Thr Ser
Gln Gly Glu Met
Gln Gly Met Glu
Gln Met Ala Asp
Gln Met Asp Ala
Gln Met Glu Gly
Gln Met Gly Glu
Gln Ser Glu Thr
Gln Ser Thr Glu
Gln Thr Asp Thr
Gln Thr Glu Ser
Gln Thr Ser Glu
Gln Thr Thr Asp
Gln Val Cys Asp
Gln Val Asp Cys
Arg Ala Cys Asp
Arg Ala Asp Cys
Arg Cys Ala Asp
Arg Cys Asp Ala
Arg Cys Glu Gly
Arg Cys Gly Glu
Arg Asp Ala Cys
Arg Asp Cys Ala
Arg Asp Ser Ser
Arg Glu Cys Gly
Arg Glu Gly Cys
Arg Gly Cys Glu
Arg Gly Glu Cys
Arg Ser Asp Ser
Arg Ser Ser Asp
Ser Asp Asp Lys
Ser Asp Lys Asp
Ser Asp Arg Ser
Ser Asp Ser Arg
Ser Glu Gln Thr
Ser Glu Thr Gln
Ser Lys Asp Asp
Ser Gln Glu Thr
Ser Gln Thr Glu
Ser Arg Asp Ser
Ser Arg Ser Asp
Ser Ser Asp Arg
Ser Ser Arg Asp
Ser Thr Glu Gln
Ser Thr Gln Glu
Thr Asp Gln Thr
Thr Asp Thr Gln
Thr Glu Asn Thr
Thr Glu Gln Ser
Thr Glu Ser Gln
Thr Glu Thr Asn
Thr Asn Glu Thr
Thr Asn Thr Glu
Thr Gln Asp Thr
Thr Gln Glu Ser
Thr Gln Ser Glu
Thr Gln Thr Asp
Thr Ser Glu Gln
Thr Ser Gln Glu
Thr Thr Asp Gln
Thr Thr Glu Asn
Thr Thr Asn Glu
Thr Thr Gln Asp
Val Cys Asp Gln
Val Cys Glu Asn
Val Cys Gly Trp
Val Cys Asn Glu
Val Cys Gln Asp
Val Cys Trp Gly
Val Asp Cys Gln
Val Asp Gln Cys
Val Glu Cys Asn
Val Glu Asn Cys
Val Gly Cys Trp
Val Gly Trp Cys
Val Asn Cys Glu
Val Asn Glu Cys
Val Gln Cys Asp
Val Gln Asp Cys
Val Trp Cys Gly
Val Trp Gly Cys
Trp Ala Gly Met
Trp Ala Met Gly
Trp Cys Gly Val
Trp Cys Val Gly
Trp Gly Ala Met
Trp Gly Cys Val
Trp Gly Met Ala
Trp Gly Val Cys
Trp Met Ala Gly
Trp Met Gly Ala
Trp Val Cys Gly
Trp Val Gly Cys
OPC 31260 HCl
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
3-[[9,10-dihydro-4-(methylamino)-9,10-dioxo-1-anthryl]aminopropyl]trimethylammonium methyl sulphate
1-(2-Fluorobenzyl)-3-butyl-8-(N-acetyl-4-aminobenzyl)-xanthine
(2S,3R)-2-(4-(2-(Piperidin-1-YL)ethoxy)phenyl)-2,3-dihydro-3-(4-hydroxyphenyl)benzo[B][1,4]oxathiin-6-OL
(2S,3R)-3-(4-Hydroxyphenyl)-2-(4-{[(2S)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL
(2S,3R)-3-(4-Hydroxyphenyl)-2-(4-{[(2R)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL
6-{4-[(1-{[5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl]carbonyl}azetidin-3-yl)oxy]benzyl}-2-oxa-6-azoniaspiro[3.3]heptane
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(4-hydroxy-1-oxononan-3-yl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
4-methyl-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide
5-(dimethylsulfamoyl)-N-(diphenylmethyl)-2-(1-pyrrolidinyl)benzamide
5-Methyl-4-[(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)-[1-(1-naphthalenylmethyl)-3-indolyl]methyl]-1,2-dihydropyrazol-3-one
1-[5-(Diethylsulfamoyl)-2-(4-methyl-1-piperazinyl)phenyl]-3-(2-fluorophenyl)urea
N-(1,3-benzodioxol-5-ylmethyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-4-ylethyl]-2,2,2-trifluoroacetamide
2-[(5,5-dimethyl-6H-[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)thio]-1-[4-(2-methoxyphenyl)-1-piperazinyl]ethanone
3,17beta-dihydroxyestra-1,3,5(10)-trien-2-yl beta-D-glucopyranosiduronate
16alpha,17alpha-dihydroxyestra-1(10),2,4-trien-3-yl beta-D-glucopyranosiduronate
Glycine, L-gamma-glutamyl-S-[2-hydroxy-1-(2-oxoethyl)heptyl]-L-cysteinyl-
3,16alpha-dihydroxyestra-1(10),2,4-trien-17alpha-yl beta-D-glucopyranosiduronate
16beta,17beta-dihydroxyestra-1(10),2,4-trien-3-yl beta-D-glucopyranosiduronate
3,17beta-dihydroxyestra-1(10),2,4-trien-4-yl beta-D-glucopyranosiduronate
estriol 16-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of estriol 16-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
3,17alpha-dihydroxyestra-1(10),2,4-trien-16alpha-yl beta-D-glucopyranosiduronate
3,17beta-dihydroxyestra-1(10),2,4-trien-16beta-yl beta-D-glucopyranosiduronate
2,17beta-dihydroxyestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
4,17beta-dihydroxyestra-1(10),2,4-trien-3-yl beta-D-glucopyranosiduronate
2-[2-[2-[(4-Tert-butyl-2,6-dimethylphenyl)thio]ethyl]-1-pyridin-1-iumyl]-1-(4-nitrophenyl)ethanone
N4-(2-amino-5-thiophen-2-ylphenyl)-N1-[2-(4-methyl-1-piperazinyl)ethyl]benzene-1,4-dicarboxamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
1-[(2S,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-(2-methoxyphenyl)urea
[(2R,4R)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-3,4-dihydro-2H-pyran-6-yl]-(1-piperidinyl)methanone
1-[(2S,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(2-methoxyphenyl)urea
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
1-(4-chlorophenyl)-3-[(2S,3R,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2R,3R,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2S,3S,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-[(2S,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(2-methoxyphenyl)urea
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
1-(4-chlorophenyl)-3-[(2R,3S,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2S,3S,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2S,3R,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2R,3S,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2R,3R,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
(6S,7R,8R)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
2,2-dimethylpropanoyloxymethyl (2S,5S,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
estra-1,3,5(10)-triene-3,16alpha,17beta-triol 17-D-glucuronide
SM1-71
SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines[1][2][3].
Takeda103A
Takeda103A is a potent inhibitor of GRK2. G protein-coupled receptors (GPCRs) are central to many physiological processes. Takeda103A has the potential for the research of heart failure[1].